News | October 24, 2006

Dissolving Stent Being Tested in New Zealand, Europe

A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested by scientists.

The first human experiment with the dissolving stent is being conducted with 26 patients at hospitals in New Zealand and Europe, the Associated Press reported. The study is designed to test whether the stent is safe enough to be used in larger studies.

Thirty days after receiving the stents, all the patients are doing well, Dr. John Ormiston of Auckland, New Zealand, said Tuesday at a meeting of cardiologists in Washington, D.C.

The stent is made of the same kind of material as some dissolvable stitches but is designed to last longer than the stitches. Tests in animals suggest that the stent completely dissolves within two years, the AP reported.

Millions of people worldwide have received stents -- tiny metal-mesh tubes -- to hold open arteries after doctors have dealt with fatty deposits that clogged the arteries. The stents are viewed as a way to prevent heart attacks without the need for open-heart surgery.

However, recent research suggests that drug-coated stents -- the most popular type -- can cause potentially deadly blood clots months or years after they're placed in patients, the AP reported.

A stent that could do its job and then dissolve would be "a major milestone," Ormiston said.


Related Content

News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
News | Stents

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

Home April 17, 2024
Home
News | Stents

March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact ...

Home March 08, 2024
Home
News | Stents

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
News | Stents

November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

Home November 29, 2023
Home
News | Stents

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
News | Stents

June 13, 2023 — W. L. Gore & Associates (Gore) announced the initiation of the Gore VBX FORWARD Clinical Study ...

Home June 13, 2023
Home
News | Stents

March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...

Home March 05, 2023
Home
Subscribe Now